Premier Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $7.67M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $7.89M | Sell |
|
|||||
|
2019
Q2 | $11.6M | Sell |
|
|||||
|
2019
Q1 | $12.1M | Buy |
|
|||||
|
2018
Q4 | $1.55M | Sell |
|
|||||
|
2018
Q3 | $12.2M | Sell |
|
|||||
|
2018
Q2 | $11.1M | Buy |
|
|||||
|
2018
Q1 | $2.19M | Buy |
|
|||||
|
2017
Q4 | $1.26M | Sell |
|
|||||
|
2017
Q3 | $7.65M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $9.94M | Sell |
|
|||||
|
2016
Q2 | $9.86M | Buy |
|
|||||
|
2016
Q1 | $9.78M | Buy |
|
|||||
|
2015
Q4 | $13.3M | Sell |
|
|||||
|
2015
Q3 | $11.1M | Buy |
|
|||||
|
2015
Q2 | $12.8M | Buy |
|
|||||
|
2015
Q1 | $12.2M | Buy |
|
|||||
|
2014
Q4 | $12.7M | Buy |
|
|||||
|
2014
Q3 | $11.3M | Buy |
|